Prevalence of radiologic evidence of metastatic pancreatic ductal adenocarcinoma (PDAC) at first post-operative restaging studies in patients (pts) undergoing pancreatic cancer surgery with curative intent.

Authors

null

Sofia Palacio

Jackson Memorial Hospital, Miami, FL

Sofia Palacio , Peter Joel Hosein , Joe U Levi , Jaime R. Merchan , Jorge Monge , Lorraine Portelance , Isildinha M. Reis , Caio Max S. Rocha Lima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Prevention, Diagnosis, and Screening

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 225)

DOI

10.1200/jco.2016.34.4_suppl.225

Abstract #

225

Poster Bd #

B13

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Reconstructing the tumor microenvironment to unlock therapeutic options in pancreatic cancer.

Reconstructing the tumor microenvironment to unlock therapeutic options in pancreatic cancer.

First Author: Ben George

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Molecular precision medicine in pancreatic cancer: A single-center experience.

Molecular precision medicine in pancreatic cancer: A single-center experience.

First Author: Anthony Tarabay

Poster

2022 ASCO Gastrointestinal Cancers Symposium

A multi-institutional study of the impact of the COVID-19 pandemic on pancreatic cancer diagnosis and management.

A multi-institutional study of the impact of the COVID-19 pandemic on pancreatic cancer diagnosis and management.

First Author: Claudia Rosso

Poster

2021 Gastrointestinal Cancers Symposium

Real-world outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma.

Real-world outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma.

First Author: Laura Miotke